DNA ploidy and S-phase fraction as prognostic factors in cervical cancerROTHENBERG, M. L.Cancer treatment and research. 1994, Vol 70, pp 53-62, issn 0927-3042Article

Topoisomerase I inhibitors : Review and updateROTHENBERG, M. L.Annals of oncology. 1997, Vol 8, Num 9, pp 837-855, issn 0923-7534Article

The role of intraperitoneal chemotherapy in ovarian cancerMARKMAN, M.Cancer treatment and research. 1994, Vol 70, pp 73-82, issn 0927-3042Article

CPT-II : An original spectrum of clinical activityROTHENBERG, M. L.Seminars in oncology. 1996, Vol 23, Num 1, pp 21-26, issn 0093-7754, SUP3Conference Paper

Multidrug resistance in cancer chemotherapyPATEL, N. H; ROTHENBERG, M. L.Investigational new drugs. 1994, Vol 12, Num 1, pp 1-13, issn 0167-6997Article

Update on the Bethesda system for reporting cervical/vaginal diagnosesVALENTE, P. T.Cancer treatment and research. 1994, Vol 70, pp 15-28, issn 0927-3042Article

Efficacy and toxicity of irinotecan in patients with colorectal cancerROTHENBERG, M. L.Seminars in oncology. 1998, Vol 25, Num 5, pp 39-46, issn 0093-7754, SUP11Article

Oncogene expression in cervical cancerBAKER, V. V.Cancer treatment and research. 1994, Vol 70, pp 43-51, issn 0927-3042Article

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group studyROTHENBERG, M. L; BENEDETTI, J. K; MACDONALD, J. S et al.Annals of oncology. 2002, Vol 13, Num 10, pp 1576-1582, issn 0923-7534, 7 p.Article

Phase I and pharmacokinetic trial of weekly CPT-11ROTHENBERG, M. L; KUHN, J. G; ROCK, M. K et al.Journal of clinical oncology. 1993, Vol 11, Num 11, pp 2194-2204, issn 0732-183XArticle

Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsO'SHAUGHNESSY, J. A; WITTES, R. E; BURKE et al.Journal of clinical oncology. 1991, Vol 9, Num 12, pp 2225-2232, issn 0732-183XArticle

Medical oncology in the 1990sCHABNER, B. A; ROTHENBERG, M. L.Lancet (British edition). 1991, Vol 338, Num 8766, pp 576-577, issn 0140-6736Article

Photodynamic therapy for peritoneal carcinomatosisTOCHNER, Z. A.Cancer treatment and research. 1994, Vol 70, pp 83-91, issn 0927-3042Article

Prognostic value of progesterone receptors in endometrial cancerKLEINE, W. W.Cancer treatment and research. 1994, Vol 70, pp 93-100, issn 0927-3042Article

The role of human papillomavirus in the genesis of cervical cancerKITCHENER, H. C.Cancer treatment and research. 1994, Vol 70, pp 29-41, issn 0927-3042Article

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeksROTHENBERG, M. L; KUHN, J. G; ELFRING, G. L et al.Annals of oncology. 2001, Vol 12, Num 11, pp 1631-1641, issn 0923-7534Article

Matrix metalloproteinases : Biologic activity and clinical implicationsNELSON, A. R; FINGLETON, B; ROTHENBERG, M. L et al.Journal of clinical oncology. 2000, Vol 18, Num 5, pp 1135-1149, issn 0732-183XArticle

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposideHAMMOND, L. A; ECKARDT, J. R; VON HOFF, D. D et al.Clinical cancer research. 1998, Vol 4, Num 6, pp 1459-1467, issn 1078-0432Article

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerSHAPIRO, J. D; ROTHENBERG, M. L; SAROSY, G. A et al.Cancer. 1998, Vol 83, Num 9, pp 1980-1988, issn 0008-543XArticle

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancerROTHENBERG, M. L; ECKARDT, J. R; WEISS, G. R et al.Journal of clinical oncology. 1996, Vol 14, Num 4, pp 1128-1135, issn 0732-183XArticle

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinomaBLANKE, C. D; HALLER, D. G; BENSON, A. B et al.Annals of oncology. 2001, Vol 12, Num 11, pp 1575-1580, issn 0923-7534Article

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinomaROTHENBERG, M. L; COX, J. V; MOHRLAND, J. S et al.Cancer. 1999, Vol 85, Num 4, pp 786-795, issn 0008-543XArticle

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerROTHENBERG, M. L; MOORE, M. J; STORNIOLO, A.-M et al.Annals of oncology. 1996, Vol 7, Num 4, pp 347-354, issn 0923-7534, 7 p.Article

Neoadjuvant chemotherapy in cervix cancerDOTTINO, P. R; SEGNA, R. A.Cancer treatment and research. 1994, Vol 70, pp 63-71, issn 0927-3042Article

New anticancer agentsWEISS, G. R; BURRIS, H. A; ECKARDT, J. R et al.Cancer chemotherapy and biological response modifiers annual. 1993, Vol 14, pp 118-128, issn 0921-4410Article